Home › Funds › Carnegie Investment Counsel › SYK
Carnegie Investment Counsel position in SYK
STRYKER CORPORATION · Health Care
Carnegie Investment Counsel reported holding 226,577 shares of SYK (STRYKER CORPORATION) in its Q3 2026 13F filing — a position valued at US$60.8M, representing 1.21% of its reported portfolio and ranking #15 among its reported holdings. Carnegie Investment Counsel has disclosed SYK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Carnegie Investment Counsel's SYK position evolved
Carnegie Investment Counsel first disclosed a stake in SYK in Q3 2023 at 95,744 shares (US$26.2M). The position peaked in Q2 2025 at 206,974 shares, worth US$81.9M. Across 13 filings, Carnegie Investment Counsel increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 226,577 shares valued at US$60.8M — a reduction of -1,997 shares quarter over quarter.. Notable position changes include a 79% increase in Q1 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 95.74K | $26.16M | New |
| Q4 2023 | 96.24K | $28.82M | Add |
| Q1 2024 | 101.14K | $36.19M | Add |
| Q2 2024 | 115.20K | $39.20M | Add |
| Q3 2024 | 112.45K | $40.62M | Reduce |
| Q4 2024 | 114.18K | $41.11M | Add |
| Q1 2025 | 204.54K | $72.99M | Add |
| Q2 2025 | 206.97K | $81.89M | Add |
| Q3 2025 | 210.73K | $77.90M | Add |
| Q4 2025 | 221.86K | $77.98M | Add |
| Q1 2026 | 242.98K | $77.97M | Add |
| Q2 2026 | 228.57K | $70.19M | Reduce |
| Q3 2026 | 226.58K | $60.84M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SYK and 13F data
SYK (STRYKER CORPORATION) is a Health Care company. 23 other funds we track also report a position in SYK — the largest reported positions include GREENLEAF TRUST (US$4.17B), PRICE T ROWE ASSOCIATES INC /MD/ (US$3.75B), JPMorgan Chase & Co (US$3.42B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SYK
- GREENLEAF TRUST 15.16M sh · $4.17B · Q3 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.92M sh · $3.75B · Q2 2026
- JPMorgan Chase & Co 12.28M sh · $3.42B · Q3 2026
- Wellington Management Group 8.17M sh · $2.57B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.17M sh · $2.57B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 4.93M sh · $1.62B · Q2 2026
- Arrowstreet Capital 3.28M sh · $1.03B · Q2 2026
- First Western Trust Bank 3.02M sh · $949.98M · Q2 2026
- Fundsmith LLP 2.91M sh · $917.39M · Q2 2026
More on Carnegie Investment Counsel
FAQ
How long has Carnegie Investment Counsel held SYK?
Carnegie Investment Counsel has disclosed SYK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Carnegie Investment Counsel's current position in SYK?
As of Q3 2026, Carnegie Investment Counsel holds 226.58K shares of SYK (STRYKER CORPORATION), valued at $60.84M, representing 1.21% of its reported portfolio and ranking #15.
Has Carnegie Investment Counsel been buying or selling SYK?
In the latest 13F filing (Q3 2026), Carnegie Investment Counsel reduced its position in SYK. The position peaked in Q2 2025 at 206.97K shares.
Which other funds hold SYK?
Other major institutional holders of SYK include GREENLEAF TRUST, PRICE T ROWE ASSOCIATES INC /MD/, JPMorgan Chase & Co, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.